360Disruption FZE — founded by Anjo De Heus, a UAE-based venture studio bridging innovation between the United States and the Gulf region. The company localizes healthtech, biotech, and AI solutions to create FDI, jobs, and lasting impact in line with UAE Vision 2031 and the Make It in the Emirates initiative.
360Disruption Bridging U.S. health innovation with GCC execution and African-scale impact. Diagnostics • FDI • Health Equity

We bridge U.S. health innovation with Gulf commercialization and African-scale deployment.

360Disruption transforms breakthrough diagnostics, telehealth, biotech, and sustainability technologies into impactful, revenue-generating solutions across the Gulf region and Africa.

From concept to commercialization — from pilot to national rollout.

💼 Join 360Disruption as an Investor — Partner for Impact & Growth

Why Invest in 360Disruption

The global demand for accessible, scalable health-tech, diagnostics, and infrastructure is skyrocketing — especially across the Gulf and Africa.

By investing in 360Disruption, you align with a company that:

  • Bridges U.S. innovation with GCC execution and African deployment

  • Has privileged access to governments, regulatory frameworks, and free-zone systems

  • Executes real-world projects — not just ideas — delivering measurable social and financial returns

  • Operates across diverse, complementary verticals: diagnostics, telehealth, biotech, FDI-led manufacturing, and public-private partnerships

When you invest, you participate in a platform designed for impact, scale, and long-term value.


📈 What We Offer — High-Leverage Investment Opportunities

1. Strategic Access

As an investor in 360Disruption, you gain exposure to opportunities that few can reach:

  • National-scale diagnostics rollouts

  • Telehealth infrastructure in under-served regions

  • FDI-backed manufacturing and supply chains

  • Government-level health programs

2. Diversified Portfolio with Real Assets & High Potential

Our portfolio spans multiple verticals and geographies — reducing risk and improving resilience:

  • Diagnostics & molecular health (GCC + Africa)

  • Biotech & longevity platforms

  • Public-private health initiatives

  • Regulatory-compliant commercial manufacturing

3. Recurring Revenue & Impact-Driven Returns

Many of our projects build recurring value through service contracts, licensing, per-test revenues, and long-term government partnerships. Your investment supports sustainable growth — not one-off wins.

4. Transparency, Governance & Trust

We adhere to high standards of governance, ethical conduct, and transparency. As a partner, you’ll receive regular updates, access to project pipelines, and clear visibility into milestones and progress.


🔍 Who This Opportunity Is For

  • Institutional investors, private equity and family offices seeking high-impact opportunities in emerging markets

  • Impact-investment funds focused on healthcare, sustainable development, and social outcomes

  • Investors looking for diversified exposure across the GCC and Africa with the security of U.S.-based strategic management

  • Long-term partners interested in supporting national-scale health and infrastructure development


🛠 How We Work with Investors

  1. Introductory Briefing — Receive a confidential investor deck with project pipelines, market assessments, and ROI models.

  2. Due Diligence & Structuring — Evaluate projects, regulatory environment, and potential returns. Decide on investment type (equity, convertible note, project financing, etc.).

  3. Commitment & Onboarding — Sign partnership agreement. Gain governance and oversight access.

  4. Deployment & Growth — Funds are allocated to projects, deployment begins, and you receive regular performance updates and reporting.

  5. Scaling & Returns — As operations scale, you benefit from recurring revenues, equity growth, and social impact.


🌍 Our Track Record & Pipeline

360Disruption currently has:

  • Active engagements and MOUs with several governments in Africa 

  • Diagnostics & telehealth pilot programs ready for deployment

  • A growing portfolio of biotech and longevity projects sourced from U.S. innovators

  • A scalable model for regional expansion and recurring revenue

As an investor, you join at a moment of high leverage — when early capital can yield outsized returns and impact.


🤝 Ready to Explore This Opportunity?

If you are interested in gaining institutional exposure to frontier health-tech, diagnostics, and emerging-market impact — let’s start a conversation.

We deliver opportunity with structure. Growth with governance. Innovation with impact.

info@360disruption.com

Let’s build something that matters together.

Invest in 360disruption and become an investor in our ventures automatically

Ready to become part of a movement?

360Disruption.com — Where Global Innovation Becomes National Impact

360Disruption is the execution engine behind some of the most ambitious expansions across the GCC and Africa.
We work with innovators, investors, and governments to commercialize breakthrough technologies, build sovereign capabilities, and open markets at national scale.

We are not consultants — we are partners in execution.
We don’t produce theory — we deliver operational outcomes.

From diagnostics to advanced manufacturing and AI-enabled infrastructure, 360Disruption turns vision into acceleration and strategy into momentum.

Build bigger. Scale faster. Execute with conviction.

📍 Cross-continental reach | Government partnerships | High-impact commercialization

👉 Ready to redefine your trajectory? Contact us today.

Made with Purpose and Precision by 360Disruption F.Z.E.
© 2026

 

360Disruption FZE — founded by Anjo De Heus, a UAE-based venture studio bridging innovation between the United States and the Gulf region. The company localizes healthtech, biotech, and AI solutions to create FDI, jobs, and lasting impact in line with UAE Vision 2031 and the Make It in the Emirates initiative.
360Disruption FZE — founded by Anjo De Heus, a UAE-based venture studio bridging innovation between the United States and the Gulf region. The company localizes healthtech, biotech, and AI solutions to create FDI, jobs, and lasting impact in line with UAE Vision 2031 and the Make It in the Emirates initiative.